In
a recent decision of the EPO Boards of Appeal, T2003/08 the following claim was
held to be a legitimate medical use claim despite the fact that it seems to
refer to a device.
1.
Use of a specific ligand for human immunoglobulin
in
the manufacture of a column having said ligand
coupled
thereto for the treatment of a patient
suffering
from dilated cardiomyopathy, said treatment
comprising
passing plasma of the patient over the
column
under conditions which effect the binding of
said
specific ligand to immunoglobulin in the patient's
plasma,
thereby removing a significant portion of the
immunoglobulin
from the patient's plasma, and
reinfusing
the plasma to the patient.
This
is a significant decision because under EPO case law medical use claims must
refer to medicaments which are ‘substances’ and this term has been judged to
not include devices. In general
therefore medical use claims cannot be used to obtain protection for devices at
the EPO. However the present case
demonstrates there is a lot of leeway in judging whether or not the invention
concerns a ‘substance’. Here a ligand
attached to a column was still judged to be a substance. That means that there is going to continue to
be uncertainty in this area. Another
implication is that when drafting cases which concern devices careful
consideration should be given to way the way the claim is worded bearing in
mind that it needs to refer to a substance.
You may wish to see related articles Top 10 Debatable aspects of biotech and Patent Topics in the UK and Ways to limit a medical use claim
No comments:
Post a Comment